Log in to save to my catalogue

Stereotactic body radiation therapy is superior to sorafenib in terms of survival in patients with h...

Stereotactic body radiation therapy is superior to sorafenib in terms of survival in patients with h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2157666778

Stereotactic body radiation therapy is superior to sorafenib in terms of survival in patients with hepatocellular carcinoma

About this item

Full title

Stereotactic body radiation therapy is superior to sorafenib in terms of survival in patients with hepatocellular carcinoma

Author / Creator

Publisher

Germany

Journal title

Strahlentherapie und Onkologie, 2019-02, Vol.195 (2), p.188-189

Language

German

Formats

Publication information

Publisher

Germany

More information

Alternative Titles

Full title

Stereotactic body radiation therapy is superior to sorafenib in terms of survival in patients with hepatocellular carcinoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2157666778

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2157666778

Other Identifiers

E-ISSN

1439-099X

DOI

10.1007/s00066-018-1408-x

How to access this item